Navigation Links
Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call
Date:11/6/2009

PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced plans to release its third quarter 2009 results before market on Monday, November 16, 2009. The Company will hold a conference call that same day to discuss the results at 11:00 am EST. Interested parties should call (866) 788-0546 (domestic) or (857) 350-1684 (international), with passcode 81416481 to access the call. You may also access this call via the Internet at:

http://phx.corporate-ir.net/playerlink.zhtml?c=107533&s=wm&e=2539678

For those who are unavailable to listen to the live broadcast, a replay will be available through December 16, 2009 and can be accessed by dialing 888-286-8010 (domestic), and 617-801-6888 (international). The passcode is 43541503.

About Derma Sciences

Derma Sciences is a specialty medical device / pharmaceutical company focusing on advanced wound care. Its key product, MEDIHONEY®, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was the focus of a positive large-scale randomized controlled trial on leg ulcers. Derma's recently FDA cleared BIOGUARD(TM) Barrier Dressing is the Company's latest new product entrant into the $14 billion global wound care market. The barrier technology was licensed from Quick-Med Technologies, Inc. in Q1 of 2007. Derma also has in development DSC127, a novel angiotensin analog for accelerated wound healing and scar reduction. DSC127 was licensed from the University of Southern California in Q4 of 2007. Patient enrollment for a Phase II study began in Q4 of 2008. Resu
'/>"/>

SOURCE Derma Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R)
2. Shire Reports Tolerability and Clinical Effects Results of Daytrana(R) (methylphenidate transdermal system) from Study in Adolescents with ADHD
3. Derma Sciences Announces Multiple Clinical Presentations of MEDIHONEY(R) at Upcoming Major Wound Care Conference
4. Estrogen Getting Cool Reception From Dermatologists for Mixed Results in Improving Appearance of Skin
5. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
6. BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
7. Clinical Trial Results of Pollogens TriPollar(TM) Radio Frequency Technology published in the Journal of the European Academy of Dermatology and Venereology
8. Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study
9. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
10. Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis
11. Emerging Therapies Could Help Ease The Chronic Symptoms of Atopic Dermatitis For Adults and Children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... , Switzerland , February 9 ... global biopharmaceutical group of companies with,a focus ... target unmet medical,needs, today announced the signature ... the development, manufacture and commercialisation of Debio ... with a,potent anti-hepatitis C virus (HCV) effect. ...
(Date:2/8/2010)... PreXion, Inc., ( www.prexion.com ) the ... for dentistry, today announced that it has appointed ... PreXion President/COO Robert Meier commented, "We are ... and I look forward to working with him in ... and success in the dental and high tech medical ...
(Date:2/8/2010)... Feb. 8 Rapid developments ... steady increase in the use and cost of ... arthritis and psoriasis. This has led to some ... costs and medication coverage being spread over both ... new solution with Medication Cost Integration (MCI), which ...
Breaking Medicine Technology:Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3PreXion, Inc. Announces Appointment of Director of Marketing 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 2RegenceRx Leads the Industry With Introduction of Medication Cost Integration 3Doctor Building Nutritarian Army to Fight Disease 65240 1Doctor Building Nutritarian Army to Fight Disease 65240 2Doctor Building Nutritarian Army to Fight Disease 65240 3Hakuna Staff Scheduling Software is Proud To Announce the Launch of Its Online Employee Scheduling Program 65238 1Hakuna Staff Scheduling Software is Proud To Announce the Launch of Its Online Employee Scheduling Program 65238 2Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 15419 1Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 15419 2Endo and Jubilant Expand Oncology Discovery Partnership on Successful Delivery of Early Milestone 15419 3
... - Results from phase III,clinical trials and further ... of the European Academy of,Dermatology and Venereology (EADV). ... alitretinoin as a potential once,daily oral treatment for ... no approved treatment exists for severe Chronic Hand,Eczema ...
... MENLO PARK, Calif.--(BUSINESS WIRE)--May,21, 2007 - ChemGenex ... of new clinical data relevant to the ... and the T315I mutation in Philadelphia-positive leukemias",by ... University of,Bologna, Italy (Haematologica Volume 92, pages ...
Other Medicine Technology:Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 2Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 3Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 4Efficacy and Safety Profile of Basilea's Alitretinoin for Severe,Refractory Chronic Hand Eczema Confirmed by Data Shown at European,Dermatology Congress 5Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 2Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 3
(Date:2/9/2010)... EAST LANSING, Mich.- Michigan State University has launched ... designed to address product counterfeiting- which the FBI ... , The counterfeiting of products- from pharmaceuticals to ... of billions of dollars in global trade and ... the economy, the environment and national security. Terrorist ...
(Date:2/9/2010)... fictional television drama may be more effective in persuading ... program on the same issue, according to a new ... a televised drama about a teen pregnancy felt more ... led to more support for using birth control. , ... difficulties caused by teen pregnancies were unmoved, and had ...
(Date:2/9/2010)... MD -- The first results from a large-scale ... African countries reveal that a high percentage of ... quality and thus may contribute to the growth ... the most virulent form of malaria. The findings, ... Medicines (PQM) Program, a USAID-funded program implemented by ...
(Date:2/9/2010)... The following is a statement by PolicyLink ... childhood obesity epidemic will require the kind of clear-eyed ... ,, "As the First Lady stressed, too many ... soda -- and few healthy food options. For many ... extends far beyond the school yard. Millions of poor ...
(Date:2/9/2010)... The Quantum Foundation is proud to be ... Palm Beach County that will help kids and ... Johnson Foundation (RWJF) recently announced a $360,000 grant ... healthy foods for children and families in Lake Worth ... a rigorous selection process that drew more than 500 proposals ...
Breaking Medicine News(10 mins):Health News:MSU launches first anti-counterfeiting research program 2Health News:MSU launches first anti-counterfeiting research program 3Health News:TV drama can be more persuasive than news program, study finds 2Health News:TV drama can be more persuasive than news program, study finds 3Health News:TV drama can be more persuasive than news program, study finds 4Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 2Health News:One-third of antimalarial medicines sampled in 3 African nations found to be substandard 3Health News:Planting Seeds to Fight Childhood Obesity 2
... stages of pregnancy seems to increase the size of the infant, ... fish // may boost the fetal growth rate during pregnancy. They ... was to deliver a low birth weight baby. ,Researchers ... pregnancies. In women who ate no fish, that rate increased to ...
... Recent research show individuals in lower socioeconomic groups, as measured ... with // higher socioeconomic status, but their stress is more ... those with more education have more days of stress, they ... more than 1,000 adults were interviewed daily for eight days, ...
... link between certain types of bedding and frequent wheezing ... an association between frequent wheezing and synthetic quilts and ... were those reported as foam, sponge, tontine, polyester or ... were classified as synthetic. ,The study also shows ...
... to a complex disorder that combines a chronic activation of ... of T-cells, which are involved in immune response. If the ... weakened immune system is less able to fight infections, and ... drug that suppresses the immune system can delay the onset ...
... caffeine throughout the day is found to be a more ... their findings researchers say, most of the population is using caffeine ... tea in the morning, or three cups on the way to ... falling as the day goes on. ,Nearly 20 male participants ...
... Researchers say they now think they have discovered a way ... called the early // prostate cancer antigen, or EPCA can ... development of cancer . ,However specialists, says one ... of prostate cancer is that PSA levels often fluctuate. They ...
Other Medicine News:
... Healing Shoe offers the most advanced design ... allowing patients to maintain their mobility. Thanks ... even larger portion of the forefoot is ... heads and toes to heal faster. OrthoWedge ...
The choice for inclement weather. This boot provides both closed toe and heel with a moisture resistant vinyl upper....
Ideal for use with thinner casting materials such as polyester or fiberglass. Conforms to any casting material....
This lightweight cast boot features a sturdy canvas upper. The three layer EVA rocker outsole provides excellent shock absorption....
Medicine Products: